Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 85/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

9%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results60% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (8)
P 3 (1)

Trial Status

Unknown3
Completed3
Terminated2
Active Not Recruiting1
Not Yet Recruiting1
Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (11)

Research Network

Activity Timeline